四川医学
四川醫學
사천의학
Sichuan Medical Journal
2015年
10期
1371-1373
,共3页
曹德宏%汤壮%魏强%鄢世兵
曹德宏%湯壯%魏彊%鄢世兵
조덕굉%탕장%위강%언세병
输尿管癌%诊断%治疗
輸尿管癌%診斷%治療
수뇨관암%진단%치료
ureteral carcinoma%diagnosis%treat
目的 分析我院原发性输尿管癌的临床资料,探讨输尿管癌的临床特点. 方法 对96例经手术病理证实的原发性输尿管癌的临床资料进行回顾性研究分析. 结果 本研究组男48例,女48例,平均发病年龄68岁. 69例均行手术治疗,以输尿管癌根治术为主( 69例,71. 9%). 病理诊断结果均为尿路上皮癌. 最常见症状是血尿. 96例获得随访,随访时间为3~150个月. 总2年生存率77. 7%,总5年生存率54. 5%,总十年生存率50. 3%. 结论 肿瘤的分期和分级是影响预后的重要因素,低分期、低分级的原发性输尿管癌也许预后更好. 因此早诊断及早治疗,密切随访对于提高输尿管癌患者的生存率是重要的.
目的 分析我院原髮性輸尿管癌的臨床資料,探討輸尿管癌的臨床特點. 方法 對96例經手術病理證實的原髮性輸尿管癌的臨床資料進行迴顧性研究分析. 結果 本研究組男48例,女48例,平均髮病年齡68歲. 69例均行手術治療,以輸尿管癌根治術為主( 69例,71. 9%). 病理診斷結果均為尿路上皮癌. 最常見癥狀是血尿. 96例穫得隨訪,隨訪時間為3~150箇月. 總2年生存率77. 7%,總5年生存率54. 5%,總十年生存率50. 3%. 結論 腫瘤的分期和分級是影響預後的重要因素,低分期、低分級的原髮性輸尿管癌也許預後更好. 因此早診斷及早治療,密切隨訪對于提高輸尿管癌患者的生存率是重要的.
목적 분석아원원발성수뇨관암적림상자료,탐토수뇨관암적림상특점. 방법 대96례경수술병리증실적원발성수뇨관암적림상자료진행회고성연구분석. 결과 본연구조남48례,녀48례,평균발병년령68세. 69례균행수술치료,이수뇨관암근치술위주( 69례,71. 9%). 병리진단결과균위뇨로상피암. 최상견증상시혈뇨. 96례획득수방,수방시간위3~150개월. 총2년생존솔77. 7%,총5년생존솔54. 5%,총십년생존솔50. 3%. 결론 종류적분기화분급시영향예후적중요인소,저분기、저분급적원발성수뇨관암야허예후경호. 인차조진단급조치료,밀절수방대우제고수뇨관암환자적생존솔시중요적.
Objective Aim to analyze the clinical pathologic characteristics of primary ureteral carcinoma patients who underwent surgical therapy in the Department of the West China Hospital of Sichuan University. Methods Retrospectively ana-lyze the data of 96 cases were proved with ureteral cancer by pathology. Resutls This study included 48 male and 48 female pa-tients. The average age of morbidity was 68 years old. All the cases underwent surgical operations,and total nephroureterectomy was performed in 69 cases of patients. The haematuria is the most common symptom. All the 96 patients were urological epithelial carci-noma. All the 96 cases were followed up from 3-150 months. The 2 year,5 year and 10 year survival rates were 77. 7%,54. 5% and 50. 3%. Conclusion Tumor stage and grade are both the prognostic factors. Primary ureteral carcinoma with lower stage and grade might have better prognosis. Therefore, the early diagnosis, treatment and the regularly postoperative follow-up are the key points for the prognosis of patients with primary ureteral carinoma.